Scientific evidence-based program – Trusted by Allied Health Professionals for Type 2 diabetes

Find out more

OMNI-D® Clinically validated for managing Post Prandial blood sugar spikes

Learn more

Take control today and prevent Glucose excursions

Learn more
Our Company
Latest News

Myopharm is an IND stage biotechnology company focused on developing first in class, novel therapeutics for the treatment and prevention of Type 2 diabetes. Myopharm is currently developing a number of diabetes therapeutics including a beta-cell-centric dual combination drug, to address the 50% antidiabetic treatment failures occurring in Type 2 diabetics.

In addition to this, Myopharm has a rapidly growing portfolio of clinically validated medical foods indicated in the Type 2 diabetes, Insulin Resistance and Prediabetes space and an Australian Food Standards compliant VLED weight loss food product.

See what the experts have to say about Omni - D® "Minimisation of postprandial glycaemic excursions now represents a specific target in the management of type 2 diabetes given the recognition that the magnitude of the rise in blood glucose after a meal has a major influence on glycated haemoglobin and, hence, the risk of the microvascular complications of diabetes (ie eye, kidney and nerve damage) and also appears to be an independent determinant of cardiovascular disease." - Professor Michael Horowitz


View All Reports

Latest Announcements

View All Announcements

Australian Diabetes Congress 2022 turns the spotlight on the latest breakthroughs

The Australian Diabetes Congress 2022 once again brought to light the effects of diabetes on the health system, but there were positives in the latest breakthroughs in research, education and clinical care.

The national Diabetes Services Scheme (NDSS) recorded 118,800 and over 119,000 new registrants between March 2020–2021 and March 2021–2022 – the highest recorded number of any 12-month period.

National Diabetes Week highlights

It’s a shocking statistic. More than 300 Australians, or one person every five minutes, develops diabetes every day.

Think about that: one person every five minutes.

And the number of diagnoses is multiplying daily. Currently, almost 1.9 million Australians have diabetes and close to 120,000 Australians have developed diabetes in the past year.

The Rising Global Prevelance of Diabetes

As the Covid-19 pandemic dominated the headlines over the past year, the fact that the number of people living with - and dying from - diabetes has continued to rise has gone rather unnoticed.